135 related articles for article (PubMed ID: 35905784)
1. Oral delivery of camptothecin-loaded multifunctional chitosan-based micelles is effective in reduce colorectal cancer.
Almeida A; Castro F; Resende C; Lúcio M; Schwartz S; Sarmento B
J Control Release; 2022 Sep; 349():731-743. PubMed ID: 35905784
[TBL] [Abstract][Full Text] [Related]
2. Self-aggregates of 3,6-O,O'-dimyristoylchitosan derivative are effective in enhancing the solubility and intestinal permeability of camptothecin.
Silva DS; Almeida A; Prezotti FG; Facchinatto WM; Colnago LA; Campana-Filho SP; Sarmento B
Carbohydr Polym; 2017 Dec; 177():178-186. PubMed ID: 28962756
[TBL] [Abstract][Full Text] [Related]
3. 3D printed systems for colon-specific delivery of camptothecin-loaded chitosan micelles.
Almeida A; Linares V; Mora-Castaño G; Casas M; Caraballo I; Sarmento B
Eur J Pharm Biopharm; 2021 Oct; 167():48-56. PubMed ID: 34280496
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.
Ünal S; Aktaş Y; Benito JM; Bilensoy E
Int J Pharm; 2020 Jun; 584():119468. PubMed ID: 32470483
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.
Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J
Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model.
Ünal S; Can Öztürk S; Bilgiç E; Yanık H; Korkusuz P; Aktaş Y; Benito JM; Esendağlı G; Bilensoy E
Eur J Pharm Biopharm; 2021 Dec; 169():168-177. PubMed ID: 34700001
[TBL] [Abstract][Full Text] [Related]
8. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability.
Watanabe M; Kawano K; Yokoyama M; Opanasopit P; Okano T; Maitani Y
Int J Pharm; 2006 Feb; 308(1-2):183-9. PubMed ID: 16324807
[TBL] [Abstract][Full Text] [Related]
9. Enhancing oral delivery and anticancer efficacy of 7-ethyl-10-hydroxycamptothecin through self-assembled micelles of deoxycholic acid grafted N'-nonyl-trimethyl chitosan.
Huang J; Tang X; Yang Z; Chen J; Wang K; Shi C; Liu Z; Wu M; Du Q
Colloids Surf B Biointerfaces; 2024 Feb; 234():113736. PubMed ID: 38215603
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles.
Kawano K; Watanabe M; Yamamoto T; Yokoyama M; Opanasopit P; Okano T; Maitani Y
J Control Release; 2006 May; 112(3):329-32. PubMed ID: 16678929
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.
Opanasopit P; Ngawhirunpat T; Chaidedgumjorn A; Rojanarata T; Apirakaramwong A; Phongying S; Choochottiros C; Chirachanchai S
Eur J Pharm Biopharm; 2006 Nov; 64(3):269-76. PubMed ID: 16870407
[TBL] [Abstract][Full Text] [Related]
12. Light-induced cytosolic activation of reduction-sensitive camptothecin-loaded polymeric micelles for spatiotemporally controlled in vivo chemotherapy.
Yen HC; Cabral H; Mi P; Toh K; Matsumoto Y; Liu X; Koori H; Kim A; Miyazaki K; Miura Y; Nishiyama N; Kataoka K
ACS Nano; 2014 Nov; 8(11):11591-602. PubMed ID: 25333568
[TBL] [Abstract][Full Text] [Related]
13. High Drug Loading, Reversible Disulfide Core-Cross-Linked Multifunctional Micelles for Triggered Release of Camptothecin.
Ling L; Ismail M; Du Y; Xia Q; He W; Yao C; Li X
Mol Pharm; 2018 Dec; 15(12):5479-5492. PubMed ID: 30376635
[TBL] [Abstract][Full Text] [Related]
14. Polymeric micelles based on amphiphilic oleic acid modified carboxymethyl chitosan for oral drug delivery of bcs class iv compound: Intestinal permeability and pharmacokinetic evaluation.
Kumar R; Sirvi A; Kaur S; Samal SK; Roy S; Sangamwar AT
Eur J Pharm Sci; 2020 Oct; 153():105466. PubMed ID: 32673792
[TBL] [Abstract][Full Text] [Related]
15. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.
Mu L; Elbayoumi TA; Torchilin VP
Int J Pharm; 2005 Dec; 306(1-2):142-9. PubMed ID: 16242875
[TBL] [Abstract][Full Text] [Related]
16. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells.
Wang K; Zhang T; Liu L; Wang X; Wu P; Chen Z; Ni C; Zhang J; Hu F; Huang J
Int J Nanomedicine; 2012; 7():4487-97. PubMed ID: 22927762
[TBL] [Abstract][Full Text] [Related]
17. A silica-based antioxidant nanoparticle for oral delivery of Camptothecin which reduces intestinal side effects while improving drug efficacy for colon cancer treatment.
Nguyen-Trinh QN; Trinh KXT; Trinh NT; Vo VT; Li N; Nagasaki Y; Vong LB
Acta Biomater; 2022 Apr; 143():459-470. PubMed ID: 35235866
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of 3,6-O,O'- dimyristoyl chitosan micelles for oral delivery of paclitaxel.
Silva DS; Almeida A; Prezotti F; Cury B; Campana-Filho SP; Sarmento B
Colloids Surf B Biointerfaces; 2017 Apr; 152():220-228. PubMed ID: 28113124
[TBL] [Abstract][Full Text] [Related]
19. Novel amphiphilic chitosan micelles as carriers for hydrophobic anticancer drugs.
Almeida A; Araújo M; Novoa-Carballal R; Andrade F; Gonçalves H; Reis RL; Lúcio M; Schwartz S; Sarmento B
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110920. PubMed ID: 32409071
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and antitumor mechanism of functionalized chitosan-based polymeric micelles for oral delivery of paclitaxel.
Wang X; Zheng Y; Qiu L; Ouyang H; Xu X; Xu W; Zhang Y; Xu W
Int J Pharm; 2022 Sep; 625():122138. PubMed ID: 36029990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
